New trial tests drug options for rare autoimmune disease
NCT ID NCT06941376
Summary
This study is testing how well five different standard medications work to control relapsing polychondritis, a rare disease that causes painful inflammation in cartilage. Twenty adults with mild to moderate active disease will try different drug combinations in two stages, starting with methotrexate or azathioprine, and moving to stronger biologic drugs if needed. The main goal is to see how many patients achieve remission by 26 weeks while safely tapering off steroid use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING POLYCHONDRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.